Tuesday, June 21 - Medtech Leaders
(All times in EDT)
9:15am Chair’s opening remarks
9:25am Capitalising on Medtech opportunities post Covid: the current upsurge and necessity of innovation, product development and business opportunities and how it is changing the investment landscape
During the pandemic years there was a scarcity of Medtech deals and with backlog of procedures due to the deferral of non-emergency procedures, 2022 onwards is set for a hype of activity. A panel of Medtech companies and stakeholders involved in recent mergers or acquisitions discuss:
Moderator: Jonathan Gertler, Managing Parter & CEO, Back Bay Life Science Advisors BioVentures Medtech Funds
Richard Wilmot, Head of Philips Venture Investments, Phillips
Christopher Cleary, VP Corporate Development, Medtronic
Laura Niklason, CEO, Humacyte
Townsend Goddard, Senior VP of Global Business Development, Olympus
10:05am Successful partnering between Medtech Leaders and Providers: navigating commercial success by securing the right partner at the right time
The healthcare infrastructure is under considerable strain which has resulted in changes in solution requirements and budgets. Healthcare providers are seeking cost effective and easy-to-implement products from the Medtech sector as well as new digital and supportive services. This panel will discuss how Medtech leaders are not only positioning themselves to deliver healthcare provision but also develop strategic partnerships to streamline the process. Hear which Medtech solutions are crucial to US healthcare systems and learn what opportunities leading medical device players are looking for emerging companies to bring to the table.
Moderator: Martin Kelleher, Corporate Partner and Head of the Life Sciences Team, Mason Hayes & Curran
Antonio Sanchez-Cordero, VP Business Development (M&A) Peripheral Intervention, BD
Julian Nikolchev, Senior VP Corporate Development & Strategy, Intuitive Surgical
Matthew Savary, Innovation Fund & New Ventures Principal – Medtech, UCLA Technology Development Group
10:45am Coffee break and refreshments
11:15am Investing in all MedTech: forensic review the investment interests, landscape, opportunities across medical devices, connected medical products and digital services
Medtech is ripe for growth following increasing globally revenue of over $500 billion annually and the need for patient-centric products in healthcare. New business opportunities are emerging, particularly in digital products and robotics, but with the more established companies securing the lioon’s share of investment, and market access regulatory legislation for new players unclear, where and why are investors placing their bets for this growing market?
Moderator: Katy Gardner, Partner, Brown Rudnick
Oliver Keown, Managing Director, Intuitive Ventures
Debbie Lin, Executive in Residence, DigitalDx; Former Pharma Corporate Venture Investment Executive
Lori Hu, Managing Director, Vertex Ventures
Jeffrey Schwartz, Managing Director, Bain Capital
11:55am The digital age of Medtech
Digital innovation has seen vast growth across healthcare where digital and data solutions can be applied to many medical devices’ verticals including diagnostics and surgical equipment. A panel of experts will discuss digital innovation, investment and adoption across the Medtech industry:
Moderator: Jennifer Fried, Co-Founder & CEO, Explorer Surgical
Deanna Harshbarger, VP Product, Cala Health
Thomas Hummel, Digital Transformation Corporate Development, Fresenius Kabi
David Nace, Chief Medical Officer, Innovaccer
12:35pm Value based Healthcare expansion with Real World Evidence/Data
There is continued pressure from payers on the importance of demonstrating capabilities through RWE/RWD to show how innovations will provide overall value to health systems. Those who can will be the winners in an increasingly competitive market improved market. A panel of experts will discuss the creation and expansion opportunities of value-based healthcare within the MedTech:
Moderator: Rowan Walrath, Life Sciences Reporter, Boston Business Journal
Claire Woodthorpe, VP Europe, Chief Operating Officer, Light Point Medical
Simon Blanc, Medical Director, IntegraConnect
Giles Hamilton, Chief Executive Officer, ODx Innovations
1:15pm Lunch
2:30pm MassMakes – Conditions for a Competitive and Secure Future
Ben Linville-Engler, Chief Investment Strategist and Program Executive, MassTech
2:45pm Medtech Partnering Presentation
2:55pm Medtech Partnering Presentation
Saurabh Bhasin, Vice President of M&A, Fresenius Kabi
3:15pm Coffee break and refreshments
4:00pm Regulatory Medical Device Hurdles: How to overcome challenges, de-risk development and advance new technologies for Women Health products
Kathy Lee-Sepsick, President & Chief Executive Officer, Femasys
4:30pm Panel: Mapping Medtech Market Access: Understanding the dynamics between provider, patient and product for market entry
Point of care and patient centric products are growing in demand. While this has always been at the heart of healthcare, patients are now looking to be more involved in their healthcare and the healthcare industry across the US is also looking for patients to adopt evermore new products and innovations to relieve healthcare system pressure. But, in practice, how easily are these solutions being implemented and how are medtech players working with providers to develop the right market access play?
Moderator: Jonathan Pappas, Vice President, LifeSci Communications
Bob Bargenquast, Head of U.S. Market Access Strategy & Reimbursement, Zeiss
Shani Noel, Director, Market Access & Managed Care, Respiratory Health, Baxter
Maria Shepherd, President, Medi-Vantage
Amanda Briscoe, SVP, Business Development, Veranex Solutions
5:20pm Close of Day 1
5:30pm Networking Drinks Reception
The networking drinks reception takes place Tuesday, June 21. Attendees can look forward to a fantastic night of networking and double down on their event relationship building.
Wednesday, June 22 - Break out sessions
(All times in EDT)
9:15am MedTech CEO Forum
Open to CEO, Founder, Co-Founder, President, Chairman or or c-suite executives (CFO, CBO, CCO, CSO, CMO) of US and Medtech companies.
Free to attend, pre-registration only, Chatham House Rule forum where all participants are active discussants.
Please sign-up during registration.
LSX is the Life Science eXecutive partnering community.
We connect biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.
contact | privacy policy | good conduct policy | anti-slavery policy | anti-money laundering & financial crime policy | diversity & inclusion policy | terms & conditions
© 2022 all rights reserved by LSX Ltd